ArticleExperimental & molecular medicine2018

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.

Yin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.